BlackRock, Inc. 13D and 13G filings for Candel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-27 4:25 pm Purchase | 2026-06-30 | 13G | CANDEL THERAPEUTICS INC CADL | BlackRock, Inc. BLK | 4,834,899 6.600% | 1,755,038 (+56.98%) | Filing |
| 2026-04-27 4:12 pm Purchase | 2026-03-31 | 13G | CANDEL THERAPEUTICS INC CADL | BlackRock, Inc. BLK | 3,079,861 4.200% | 220,251 (+7.70%) | Filing |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | CANDEL THERAPEUTICS INC CADL | BlackRock, Inc. BLK | 2,859,610 5.200% | 2,859,610 (New Position) | Filing |